The major reason why the said letter has gained much attention from different quarters is that it was from the office of Dr. Terrence L. Boos who is the Section Chief of the Drug and Chemical Evaluation Section. The section is under the Office of Diversion Control in the DEA and this particular letter was written to the Executive Secretary of the Board of Pharmacy of Alabama who requested a control status update on delta-8 THC. This means the contents of the letter can easily be used to juxtapose the current stand of the DEA as it applies to substance control for delta-8 THC.
Every Croptober, growers waste time on folklore instead of physics. We break down the science…
Leafly's 2026 cannabis voter guide for the midterms is the only plan you need to…
Come along on an Emerald Triangle road trip with Lindsay MaHarry to see some of…
This month an Iowa church got what every sacramental-plant congregation dreams about: a path to…
The cannabis industry does not need another study, another tax revenue report, or another state-level…
A liquor-retail trade group argued that the state’s cannabis oversight is lax and should look…